ROBO Global Healthcare Technology and Innovation ETF
ROBO Global Healthcare Technology and Innovation ETF reported 61 holdings worth US$69.1M as of Jul 31, 2026 (Form N-PORT)
As of Jul 31, 2026 · Filed Sep 28, 2026
ROBO Global Healthcare Technology and Innovation ETF reported 61 holdings worth US$69.1M as of Jul 31, 2026. Largest: Caredx, Inc., Guardant Health, Inc. and Natera, Inc. Filed Sep 28, 2026 (Form N-PORT).
- Holdings
- 61
- Value as reported
- US$69.1M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| Caredx, Inc. | 42,385 | US$1.85M | 2.7% |
| Guardant Health, Inc. | 9,878 | US$1.6M | 2.3% |
| Natera, Inc. | 5,764 | US$1.54M | 2.2% |
| Twist Bioscience Corporation | 16,853 | US$1.54M | 2.2% |
| Thermo Fisher Scientific Inc | 2,621 | US$1.51M | 2.2% |
| Medpace Holdings, Inc. | 2,539 | US$1.47M | 2.1% |
| Adaptive Biotechnologies Corporation | 64,619 | US$1.46M | 2.1% |
| Iqvia Holdings, Inc. | 6,182 | US$1.45M | 2.1% |
| Illumina, Inc. | 7,028 | US$1.44M | 2.1% |
| Arrowhead Pharmaceuticals, Inc. | 16,973 | US$1.44M | 2.1% |
| Regeneron Pharmaceuticals, Inc. | 1,789 | US$1.36M | 2.0% |
| Glaukos Corporation | 7,940 | US$1.32M | 1.9% |
| Vertex Pharmaceuticals Incorporated | 2,773 | US$1.32M | 1.9% |
| Stryker Corporation | 4,057 | US$1.32M | 1.9% |
| Livanova Plc | 16,115 | US$1.29M | 1.9% |
| Siemens Healthineers Ag | 30,197 | US$1.28M | 1.9% |
| Lonza Group Ag | 1,841 | US$1.28M | 1.9% |
| Incyte Corporation | 10,419 | US$1.25M | 1.8% |
| Abbott Laboratories | 11,713 | US$1.24M | 1.8% |
| Axogen, Inc. | 28,991 | US$1.22M | 1.8% |
| Boston Scientific Corporation | 25,562 | US$1.19M | 1.7% |
| Grail, Inc. | 17,377 | US$1.19M | 1.7% |
| Charles River Laboratories International, Inc. | 5,092 | US$1.18M | 1.7% |
| Danaher Corporation | 5,923 | US$1.15M | 1.7% |
| Tecan Group Ag | 4,974 | US$1.14M | 1.7% |
| Penumbra, Inc. | 3,558 | US$1.14M | 1.7% |
| Artivion, Inc. | 42,246 | US$1.13M | 1.6% |
| Tempus Ai, Inc. | 25,657 | US$1.13M | 1.6% |
| Koninklijke Philips N.v. | 42,743 | US$1.12M | 1.6% |
| Eurofins Scientific Se | 14,056 | US$1.1M | 1.6% |
| Irhythm Holdings, Inc. | 9,349 | US$1.1M | 1.6% |
| Conmed Corporation | 23,645 | US$1.09M | 1.6% |
| Qiagen N.v. | 26,387 | US$1.09M | 1.6% |
| Jd Health International, Inc. | 214K | US$1.08M | 1.6% |
| Edwards Lifesciences Corporation | 12,485 | US$1.07M | 1.6% |
| Crispr Therapeutics Ag | 22,018 | US$1.06M | 1.5% |
| Globus Medical, Inc. | 13,339 | US$1.05M | 1.5% |
| Bio-rad Laboratories, Inc. | 3,201 | US$1.04M | 1.5% |
| Bristol-myers Squibb Company | 15,926 | US$1.04M | 1.5% |
| Intuitive Surgical, Inc. | 2,934 | US$1.04M | 1.5% |
| Ge Healthcare Technologies Inc. | 15,208 | US$1.03M | 1.5% |
| Moderna, Inc. | 18,698 | US$1.03M | 1.5% |
| Roche Holding Ltd | 2,318 | US$1.01M | 1.5% |
| Becton, Dickinson And Company | 6,072 | US$1.01M | 1.5% |
| Agilent Technologies, Inc. | 7,096 | US$982K | 1.4% |
| Veracyte, Inc. | 20,625 | US$955K | 1.4% |
| Novanta Inc. | 6,429 | US$916K | 1.3% |
| Biomarin Pharmaceutical Inc. | 15,080 | US$905K | 1.3% |
| Novocure Limited | 60,745 | US$901K | 1.3% |
| Diasorin S.p.a. | 10,522 | US$870K | 1.3% |
| Veeva Systems Inc. | 4,131 | US$842K | 1.2% |
| Alnylam Pharmaceuticals, Inc. | 4,088 | US$840K | 1.2% |
| United Therapeutics Corporation | 1,620 | US$839K | 1.2% |
| Insilico Medicine Cayman Topco | 139K | US$807K | 1.2% |
| Align Technology, Inc. | 4,729 | US$800K | 1.2% |
| Revvity, Inc. | 6,936 | US$780K | 1.1% |
| Integra Lifesciences Holdings Corporation | 46,382 | US$772K | 1.1% |
| Smith & Nephew Plc | 48,085 | US$750K | 1.1% |
| Peptidream Inc. | 118K | US$699K | 1.0% |
| Alibaba Health Information Technology Ltd. | 1.46M | US$668K | 0.97% |
| Omnicell, Inc. | 17,112 | US$605K | 0.88% |
Source
View original at SEC
Related